Compare MDU Resources Group Inc. Common Stock (Holding Company) (MDU) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MDU Resources Group Inc. Common Stock (Holding Company) vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? MDU Resources Group Inc. Common Stock (Holding Company) trades at $18.56 (market cap $3.92B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 2.8× MDU Resources Group Inc. Common Stock (Holding Company)'s market cap, and MDU Resources Group Inc. Common Stock (Holding Company) pays the higher dividend (3.03%). Which is the better fit depends on your goals — on Pluang, investors hold MDU Resources Group Inc. Common Stock (Holding Company) for 0 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| MDU | RDY | |
|---|---|---|
Market Cap | $3.92B | $10.78B |
Volume | 1,027,656 | 2,724,343 |
Sector | Utilities | Health |
52-Week High | $22.80 | $15.38 |
52-Week Low | $18.39 | $11.38 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.45B | $10.68B |
Dividend Yield | 3.03% | 0.65% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About MDU Resources Group Inc. Common Stock (Holding Company)
MDU Resources Group, Inc. is a US holding company operating regulated electric and natural gas utility services alongside a construction materials and services business supplying asphalt, concrete, and aggregates.
Read more on MDU →About Dr. Reddy's Laboratories Ltd Common Stock
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →
